Advertisement

Handbook of HER2-Targeted Agents in Breast Cancer

  • Ricardo H Alvarez
  • Javier Cortés
  • Mary Falzon
  • Michael Gandy
  • Luca Gianni
  • Nadia Harbeck
  • Martine Piccart

Table of contents

  1. Front Matter
    Pages I-XI
  2. Angelica Fasolo, Luca Gianni
    Pages 1-13
  3. Mary Falzon, Michael Gandy
    Pages 15-27
  4. Leticia De Mattos-Arruda, Javier Cortés
    Pages 51-69
  5. Dimitrios Zardavas, Martine Piccart
    Pages 87-110

About this book

Introduction

This concise handbook provides oncologists and other healthcare providers with crucial updates in the field, including an updated review of the current understanding of the biology of the HER2 pathway, an overview of HER2-testing, and evidence-based discussions of available and emerging HER2-targeted treatment options. An essential clinical text for physicians that screen and treat patients with breast cancer and require an accessible, up-to-date survey of the dynamic treatment landscape.

Keywords

Breast cancer Cancer HER2 HER2-positive Oncology Pertuzumab Trastuzumab

Authors and affiliations

  • Ricardo H Alvarez
    • 1
  • Javier Cortés
    • 2
  • Mary Falzon
    • 3
  • Michael Gandy
    • 4
  • Luca Gianni
    • 5
  • Nadia Harbeck
    • 6
  • Martine Piccart
    • 7
  1. 1.Cancer Treatment Centers of AmericaNEWNANUSA
  2. 2.Institute of OncologyPasseig Vall d'HebronBarcelonaSpain
  3. 3.University College HospitalLondonUnited Kingdom
  4. 4.Health Service LaboratoriesLondonUnited Kingdom
  5. 5.Scientific InstituteOspedale San RaffaeleMilanItaly
  6. 6.University of MunichMunichGermany
  7. 7.Institut Jules BordetBrusselsBelgium

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-319-28216-9
  • Copyright Information Springer International Publishing Switzerland 2016
  • Publisher Name Adis, Cham
  • eBook Packages Medicine
  • Print ISBN 978-3-319-28214-5
  • Online ISBN 978-3-319-28216-9
  • Buy this book on publisher's site